VMD

Vimedimex Pharmaceutical (VMD) faces a leadership shake-up as a board member and three supervisory board members resign ahead of the 2026 Annual General Meeting scheduled for June 12. Separately, HoSE issued a reminder for late submission of Q1/2026 financial reports, raising governance concerns.

ITD was added to HOSE's margin-cut list after receiving a tax penalty for fiscal years 2022-2025, totaling VND 630.6 million. The list now includes 68 stocks, many under warning, control, or with negative profits, restricting leverage for investors.

HoSE placed VNE, DTA, VMD, and SBV under warning status from April 24, primarily for delayed submission of audited 2025 financial reports or reports receiving qualified audit opinions. VNE's warning stems from a 15-day delay, while VMD faces additional restrictions due to repeated disclosure violations. This regulatory action highlights ongoing compliance challenges for these listed entities across construction, pharmaceuticals, and consumer goods sectors.

HOSE has placed DRH Holdings (DRH), Tổng CTCP Xây dựng Điện Việt Nam (VNE), CTCP Đệ Tam (DTA), CTCP Y Dược phẩm Vimedimex (VMD), and CTCP Siam Brothers Việt Nam (SBV) under warning or control status from April 24, 2026, primarily for delayed submission of audited 2025 financial reports or reports with qualified audit opinions. This regulatory action highlights ongoing compliance issues and could affect trading liquidity and investor sentiment for these HOSE-listed stocks.

Vimedimex (VMD) received a formal reprimand from HoSE on April 15, 2026, for failing to disclose required explanations for its audited 2025 financial statements by the deadline. The statements show strong profit growth but contain audit qualifications over VND 198.9B in blocked deposits and VND 1,578B in long-term receivables from former leaders, raising governance and asset-quality concerns for investors.